Alphyn Biologics
Phase 2Enrollment Complete in CLEAR-AD1 Global Phase 2b Clinical Trial of Novel Topical for Atopic Dermatitis
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $16.5M
About
Enrollment Complete in CLEAR-AD1 Global Phase 2b Clinical Trial of Novel Topical for Atopic Dermatitis
Small Molecules
Funding History
2Total raised:$16.5M
Series A$12MNov 15, 2023
Seed$4.5MAug 15, 2022